BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/6/2026 8:32:54 AM | Browse: 9 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 118902
Country Russia
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitis
Manuscript Source Invited Manuscript
All Author List Stanislav Kotlyarov
Funding Agency and Grant Number
Corresponding Author Stanislav Kotlyarov, PhD, Department of Nurse, Ryazan State Medical University, Vysokovoltnaya 9, Ryazan 390005, Russia. skmr1@yandex.ru
Key Words Primary biliary cholangitis; Metabolic dysfunction-associated steatotic liver disease; Adipokines; Adiponectin; Leptin; Immunometabolism; Gut microbiota; Oxidative stress; Mitochondrial dysfunction; Leptin/adiponectin ratio
Core Tip The increase in metabolic disorders has led to the comorbidity of primary biliary cholangitis (PBC) and metabolic dysfunction-associated steatotic liver disease (MASLD) becoming increasingly common. Beyond simple comorbidity, these conditions cause complex immunometabolic cross-talk involving common pathways of immune dysregulation, lipid metabolism alterations, adipokine imbalance, and gut microbiota dysfunction. Recent data suggest that in patients with PBC, concomitant MASLD disrupts the characteristic hyperadiponectinemia associated with cholestasis, leading to a specific adipokine profile with an elevated leptin/adiponectin ratio. This Editorial summarizes current understanding of the pathogenetic relationships between PBC and MASLD, analyzes new clinical data on their bidirectional effects, and identifies critical gaps in knowledge. Understanding these interactions is important for developing personalized therapeutic approaches and improving treatment outcomes for patients with this increasingly recognized dual pathology.
Citation Kotlyarov S. Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitis. World J Hepatol 2026; In press
Received
2026-01-14 00:29
Peer-Review Started
2026-01-14 00:30
First Decision by Editorial Office Director
2026-01-19 08:49
Return for Revision
2026-01-19 08:49
Revised
2026-01-26 09:08
Publication Fee Transferred
Second Decision by Editor
2026-03-06 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-03-06 08:32
Articles in Press
2026-03-06 08:32
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com